These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
411 related articles for article (PubMed ID: 28626420)
1. Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management. Guo S; Huang J; Jiang H; Han C; Li J; Xu X; Zhang G; Lin Z; Xiong N; Wang T Front Aging Neurosci; 2017; 9():171. PubMed ID: 28626420 [TBL] [Abstract][Full Text] [Related]
2. [Pathophysiology of restless legs syndrome]. Miyamoto M; Miyamoto T; Iwanami M; Suzuki K; Hirata K Brain Nerve; 2009 May; 61(5):523-32. PubMed ID: 19514512 [TBL] [Abstract][Full Text] [Related]
3. Restless legs syndrome and periodic limb movements. Vetrugno R; Provini F; Montagna P Rev Neurol Dis; 2006; 3(2):61-70. PubMed ID: 16820753 [TBL] [Abstract][Full Text] [Related]
4. Restless legs syndrome in the older adult: diagnosis and management. Milligan SA; Chesson AL Drugs Aging; 2002; 19(10):741-51. PubMed ID: 12390051 [TBL] [Abstract][Full Text] [Related]
5. Restless legs syndrome: pathophysiology and modern management. Nagandla K; De S Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ; Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323 [TBL] [Abstract][Full Text] [Related]
7. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Garcia-Borreguero D; Silber MH; Winkelman JW; Högl B; Bainbridge J; Buchfuhrer M; Hadjigeorgiou G; Inoue Y; Manconi M; Oertel W; Ondo W; Winkelmann J; Allen RP Sleep Med; 2016 May; 21():1-11. PubMed ID: 27448465 [TBL] [Abstract][Full Text] [Related]
8. Management of treatment failure in restless legs syndrome (Willis-Ekbom disease). Garcia-Borreguero D; Cano-Pumarega I; Marulanda R Sleep Med Rev; 2018 Oct; 41():50-60. PubMed ID: 29602660 [TBL] [Abstract][Full Text] [Related]
9. Restless legs syndrome in patients on dialysis. Kavanagh D; Siddiqui S; Geddes CC Am J Kidney Dis; 2004 May; 43(5):763-71. PubMed ID: 15112166 [TBL] [Abstract][Full Text] [Related]
10. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications. Hornyak M; Scholz H; Kohnen R; Bengel J; Kassubek J; Trenkwalder C Sleep Med Rev; 2014 Apr; 18(2):153-64. PubMed ID: 23746768 [TBL] [Abstract][Full Text] [Related]
11. Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation. Earley CJ; Uhl GR; Clemens S; Ferré S Sleep Med; 2017 Mar; 31():71-77. PubMed ID: 27539027 [TBL] [Abstract][Full Text] [Related]
12. Restless legs syndrome: An overview of pathophysiology, comorbidities and therapeutic approaches (Review). Vlasie A; Trifu SC; Lupuleac C; Kohn B; Cristea MB Exp Ther Med; 2022 Feb; 23(2):185. PubMed ID: 35069866 [TBL] [Abstract][Full Text] [Related]
13. Non-dopaminergic vs. dopaminergic treatment options in restless legs syndrome. Wanner V; Garcia Malo C; Romero S; Cano-Pumarega I; García-Borreguero D Adv Pharmacol; 2019; 84():187-205. PubMed ID: 31229171 [TBL] [Abstract][Full Text] [Related]
14. On the pathway of an animal model for restless legs syndrome.. Manconi M; Hutchins W; Feroah TR; Zucconi M; Ferini-Strambi L Neurol Sci; 2007 Jan; 28 Suppl 1():S53-60. PubMed ID: 17235432 [TBL] [Abstract][Full Text] [Related]
15. The restless legs syndrome. Barrière G; Cazalets JR; Bioulac B; Tison F; Ghorayeb I Prog Neurobiol; 2005 Oct; 77(3):139-65. PubMed ID: 16300874 [TBL] [Abstract][Full Text] [Related]
18. Pivotal Role of Adenosine Neurotransmission in Restless Legs Syndrome. Ferré S; Quiroz C; Guitart X; Rea W; Seyedian A; Moreno E; Casadó-Anguera V; Díaz-Ríos M; Casadó V; Clemens S; Allen RP; Earley CJ; García-Borreguero D Front Neurosci; 2017; 11():722. PubMed ID: 29358902 [TBL] [Abstract][Full Text] [Related]
19. Long-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation. Mackie S; Winkelman JW CNS Drugs; 2015 May; 29(5):351-7. PubMed ID: 26045290 [TBL] [Abstract][Full Text] [Related]
20. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Paulus W; Trenkwalder C Lancet Neurol; 2006 Oct; 5(10):878-86. PubMed ID: 16987735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]